People living with human immunodeficiency virus (HIV) have impaired blood vessel function, which increases cardiovascular disease risk, according to new research published today in the American Heart Association's journal ...
Dec 17, 2020
0
8
Healthy Lactobacillus bacteria in the vagina are critical for women's health, but the accumulation of additional bacterial genera can imbalance the vaginal ecosystem. Such an imbalance may result in bacterial metabolism of ...
Dec 3, 2020
0
9
(HealthDay)—From 2010 to 2018, there was a 36.6 percent decrease in the rate of death among persons with diagnosed HIV (PWDH), according to a Vital Signs report published in the Nov. 20 issue of the U.S. Centers for Disease ...
Nov 20, 2020
0
1
Unlike so many other deadly viruses, HIV still lacks a vaccine. The virus—which continues to infect millions around the world—has proven especially tricky to prevent with conventional antibodies, in part because it evolves ...
Nov 19, 2020
0
72
Researchers are stopping a study early after finding that a shot of an experimental medicine every two months worked better than daily pills to help keep women from catching HIV from an infected sex partner.
Nov 9, 2020
0
1
(HealthDay)—In a clinical report from the American Academy of Pediatrics, published online Oct. 19 in Pediatrics, guidelines are presented for the evaluation and management of infants exposed to HIV.
Oct 20, 2020
0
4
The EU's medicines regulator on Friday gave the green light for the first injectable treatment for the HIV virus that causes AIDS, which could change the lives of millions of people.
Oct 16, 2020
0
25
Pulmonary hypertension is elevated blood pressure that occurs exclusively in the lungs. It is a deadly condition that affects an estimated 75 million people worldwide. Around 80% of them live in low- and middle-income countries. ...
Oct 9, 2020
0
1
Immune cells that can recognize residual HIV-infected cells in people living with HIV (PLWH) who take antiretroviral therapy (ART) remain active for years, says a new study published today in eLife.
Oct 6, 2020
0
26
(HealthDay)—Routine vaccination with a quadrivalent meningococcal conjugate vaccine (MenACWY) is recommended for adolescents aged 11 to 12 years with a booster at age 16 years, according to a report published in the Sept. ...
Sep 25, 2020
0
2
